Aurora Cannabis (ACB.TO) said Wednesday that non-profit group Genome British Columbia provided a research grant to the University of British Columbia (UBC) to support an Aurora-backed project focused on aroma breeding in cannabis.
Aurora's share price was down 0.9% at last look to US$5.35 on NYSE pre-market trading.
The project is looking to validate genetic and chemical markers for fruity aroma in cannabis, the company said, adding that the project aligns with its breeding goals and will allow it to enhance its breeding program with greater accuracy and efficiency on consumer-focused traits, positively impacting future innovation.
"By collaborating with UBC on this Genome BC-funded project, we are able to fully execute this aroma research without the typical financial constraints, allowing us to continue simultaneous work on additional important breeding traits, such as yield, potency and disease resistance," said Jose Celedon, director for breeding and genetics at Aurora. "We are eager to see the outcomes of our work and the impact on the future of cannabis breeding."
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.